Paper · 42653285

General Assessment of Indole Derivatives and Wnt Pathway as Potential Key Factors Against Various Diseases, with Particular Emphasis on Thyroid Tumors.

Skoczyńska AK and 2 others. Int J Mol Sci, 2026. Cited by 0 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. General Assessment of Indole Derivatives and Wnt Pathway as Potential Key Factors Against Various Diseases, with Particular Emphasis on Thyroid Tumors. Papers, record 42653285. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42653285

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: General Assessment of Indole Derivatives and Wnt Pathway as Potential Key Factors Against Various Diseases, with Particular Emphasis on Thyroid Tumors.; PubMed
Journal: Int J Mol Sci; PubMed
Year: 2026; PubMed
Publication types: Journal Article, Review; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/42653285/; PubMed
DOI: https://doi.org/10.3390/ijms27167280; PubMed
PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC13513884/; PubMed
The journal: https://conductscience.org/library/journal-index/101092791; PubMed
Citations, by iCite: 0; iCite
Revised in PubMed: 2026-09-02; PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename	ORCID iD
1	Skoczyńska AK	Anna K
2	Lewiński A	Andrzej
3	Karbownik-Lewińska M	Małgorzata	https://orcid.org/0000-0002-3045-5669

Source PubMed

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Thyroid Neoplasms	Major topic
Indoles	Major topic
Wnt Signaling Pathway	Major topic
Humans
Animals
Antineoplastic Agents

Source PubMed

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes it	Agency	Country	NIH project	Stated by
503/1-107-03/503-11-001	Medical University of Lodz			PubMed

Source PubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References179

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

Order	PMID	Title	Journal	Year	In Papers	Source
1	27,174,043	Molecular genetics of thyroid cancer.	Genet Res (Camb)	2016	https://conductscience.org/library/papers/27174043	PubMed
2	16,203,150	Synthesis of functionalized 2-aryl-5-nitro-1H-indoles and their activity as bacterial NorA efflux pump inhibitors.	Bioorg Med Chem	2006	https://conductscience.org/library/papers/16203150	PubMed
3	1,643,248	Oligomerization of indole-3-carbinol in aqueous acid.	Chem Res Toxicol	1992	https://conductscience.org/library/papers/1643248	PubMed
4	17,230,199	Frizzled/PCP signalling: a conserved mechanism regulating cell polarity and directed motility.	Nat Rev Genet	2007	https://conductscience.org/library/papers/17230199	PubMed
5	14,587,035	Melatonin reduces Fenton reaction-induced lipid peroxidation in porcine thyroid tissue.	J Cell Biochem	2003	https://conductscience.org/library/papers/14587035	PubMed
6	35,593,680	Diagnosis and treatment of thyroid cancer in adult patients - Recommendations of Polish Scientific Societies and the National Oncological Strategy. 2022 Update [Diagnostyka i leczenie raka tarczycy u chorych dorosłych - Rekomendacje Polskich Towarzystw Naukowych oraz Narodowej Strategii Onkologicznej. Aktualizacja na rok 2022].	Endokrynol Pol	2022	https://conductscience.org/library/papers/35593680	PubMed
7	7,592,064	Sattabacins and sattazolins: new biologically active compounds with antiviral properties extracted from a Bacillus sp.	J Antibiot (Tokyo)	1995	https://conductscience.org/library/papers/7592064	PubMed
8	15,573,866	Sigma receptor ligands: applications in inflammation and oncology.	Curr Opin Investig Drugs	2004	https://conductscience.org/library/papers/15573866	PubMed
9	11,975,483	New antiinfective and human 5-HT2 receptor binding natural and semisynthetic compounds from the Jamaican sponge Smenospongia aurea.	J Nat Prod	2002	https://conductscience.org/library/papers/11975483	PubMed
10	29,525,603	Melatonin suppresses thyroid cancer growth and overcomes radioresistance via inhibition of p65 phosphorylation and induction of ROS.	Redox Biol	2018	https://conductscience.org/library/papers/29525603	PubMed

1 to 10 of 179

See all 179 references

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

None in this release.

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Gene	NCBI Gene ID	Linked by	In Genes
WNT1	7,471	PubTator's text mining	https://conductscience.org/library/genes/7471

Source NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42653285

GET https://conductscience.org/api/papers/v1/42653285/references?page=2

API reference For AI assistants